Skip to content

Evaluation of bone metabolism in patients with ankylosing spondylitis

Evaluation of bone metabolism in patients with ankylosing spondylitis - Bone metabolism in AS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33084
Enrollment
300
Registered
2009-09-28
Start date
2009-10-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ankylosing spondylitis

Interventions

None listed

Sponsors

Medisch Centrum Leeuwarden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients have to fulfil the modified New York criteria for AS or bilateral sacroiliitis with bone marrow oedema on MRI. Patients have to be 18 years of age or older.

Exclusion criteria

Exclusion criteria: No informed consent. Legal incapacity.

Design outcomes

Primary

MeasureTime frame
Bone regulating and bone turnover markers, bone mineral density, disease activity, physical function, quality of life, inflammation of the entheses and inflammation of the peripheral joints. HLA-B27 and in the future possibly other AS-related genetic factors.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)